Prognostic implication of intratumoral metabolic heterogeneity in invasive ductal carcinoma of the breast.
about
Renal Cancer Stem Cells: Characterization and Targeted TherapiesDo clinical, histological or immunohistochemical primary tumour characteristics translate into different (18)F-FDG PET/CT volumetric and heterogeneity features in stage II/III breast cancer?Clinical and imaging-based prognostic factors in radioembolisation of liver metastases from colorectal cancer: a retrospective exploratory analysis.Simulating Heterogeneous Tumor Cell Populations.Hexokinase and phosphofructokinase activity and intracellular distribution correlate with aggressiveness and invasiveness of human breast carcinoma.Determination of regional lymph node status using (18)F-FDG PET/CT parameters in oesophageal cancer patients: comparison of SUV, volumetric parameters and intratumoral heterogeneity.18FDG-PET/CT for predicting the outcome in ER+/HER2- breast cancer patients: comparison of clinicopathological parameters and PET image-derived indices including tumor texture analysis.The Correlation Between Pre-treatment Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Parameters and Clinical Prognostic Factors in Pediatric Hodgkin LymphomaComparative diagnostic accuracy of 18F-FDG PET/CT for breast cancer recurrence.[(18)F]FDG PET/CT features for the molecular characterization of primary breast tumors.Pyruvate and Metabolic Flexibility: Illuminating a Path Toward Selective Cancer TherapiesPrognostic value of tumoral heterogeneity and volumetric parameters as measured by F18-FDG PET/CT in sinonasal cancer.Tumor size and proliferative marker geminin rather than Ki67 expression levels significantly associated with maximum uptake of 18F-deoxyglucose levels on positron emission tomography for breast cancers.Risk stratification in patients with advanced-stage breast cancer by pretreatment [(18) F]FDG PET/CT.CONSORT-Independent prognostic value of asphericity of pretherapeutic F-18 FDG uptake by primary tumors in patients with breast cancer.Textural features and SUV-based variables assessed by dual time point 18F-FDG PET/CT in locally advanced breast cancer.Prognostic value of intratumoral metabolic heterogeneity on F-18 fluorodeoxyglucose positron emission tomography/computed tomography in locally advanced cervical cancer patients treated with concurrent chemoradiotherapy.Correlation between tumour characteristics, SUV measurements, metabolic tumour volume, TLG and textural features assessed with 18F-FDG PET in a large cohort of oestrogen receptor-positive breast cancer patients.Texture analysis of high-resolution dedicated breast 18 F-FDG PET images correlates with immunohistochemical factors and subtype of breast cancer.Association between textural and morphological tumor indices on baseline PET-CT and early metabolic response on interim PET-CT in bulky malignant lymphomas.Diagnostic value of metabolic heterogeneity as a reliable parameter for differentiating malignant parotid gland tumors.Predictive value of intratumoral heterogeneity of F-18 FDG uptake for characterization of thyroid nodules according to Bethesda categories of fine needle aspiration biopsy results.
P2860
Q26746970-2CA2D074-E0C7-4FE0-BE50-4F86AC58F9DDQ33576007-36BA3839-2B46-4DFB-9621-9CE6A44CB2A9Q33719906-A73277CA-7DAC-49D0-8248-470BBED6721CQ36234846-1498F482-60E8-4A62-860B-C46188BC3202Q36557315-8D0697DC-C0E5-4866-BA5E-FE51487159E0Q37175679-EF781C9B-E19F-4E29-AB8C-2D6535E4CDFEQ37566580-3DC6DB6F-FDF8-4E57-814C-DC79E0948E09Q37700119-098FF24D-A746-4E8F-ADFA-8C8D6F957C2FQ38663416-14F9124C-E14D-4BC8-ACD5-D98CFBC7F629Q38677216-EDA078C5-A392-402E-891B-86514BFA12E8Q38731939-BD26C1A1-000D-42F3-BD4E-AAFB117C81B2Q40539372-120BAD56-F458-4706-9345-8F2384675A16Q41491212-EFB461BD-6B45-4687-8342-B44475E83105Q41507039-9B20105E-45D0-4F1C-B7D2-BCC10DCE08BEQ47112640-32E478F6-49AF-403C-8779-3897098F84C9Q47140400-57FECD6B-C203-402B-AEED-1430966D299CQ47142919-27759A30-9099-41E8-9D22-72A6E5604576Q48047542-E756956A-4E31-4307-A317-728F5569FEFDQ48311370-954368B9-F803-4182-A3C6-69F5B80B566EQ52868414-B1208EBE-EAB0-4EB0-BF48-318E9F281CFFQ52984818-B01108A6-AE1E-4C14-A200-2A34BFECD32BQ53516696-1A9B00CA-95A4-4916-BE9C-C800BC270F74
P2860
Prognostic implication of intratumoral metabolic heterogeneity in invasive ductal carcinoma of the breast.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Prognostic implication of intr ...... uctal carcinoma of the breast.
@ast
Prognostic implication of intr ...... uctal carcinoma of the breast.
@en
Prognostic implication of intr ...... uctal carcinoma of the breast.
@nl
type
label
Prognostic implication of intr ...... uctal carcinoma of the breast.
@ast
Prognostic implication of intr ...... uctal carcinoma of the breast.
@en
Prognostic implication of intr ...... uctal carcinoma of the breast.
@nl
prefLabel
Prognostic implication of intr ...... uctal carcinoma of the breast.
@ast
Prognostic implication of intr ...... uctal carcinoma of the breast.
@en
Prognostic implication of intr ...... uctal carcinoma of the breast.
@nl
P2093
P2860
P356
P1433
P1476
Prognostic implication of intr ...... ductal carcinoma of the breast
@en
P2093
Byeong-Cheol Ahn
Choon-Young Kim
Do-Hoon Kim
Jaetae Lee
Sang-Woo Lee
Seung Hyun Son
Shin Young Jeong
P2860
P2888
P356
10.1186/1471-2407-14-585
P407
P577
2014-08-12T00:00:00Z
P5875
P6179
1035874611